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ABSTRACT
Objective: The goal of performing this study is to prepare an oral strip, especially designed for pediatric use that provides fast onset of action with ease 
of swallowing particularly for young individuals who suffer from difficulty of swallowing, in addition provides maximum therapeutic effectiveness by 
reducing the first pass effect.
Materials and Methods: The oral strip was prepared by solvent casting technique through using different sole polymers (hydroxypropyl 
methylcellulose [HPMC] 15cp, HPMC 50cp, polyvinyl alcohol, and sodium carboxymethyl cellulose). Maltodextrin (MD) was added as the secondary 
polymer in different ratios to optimize the release parameters, and disintegration time (DT), three different plasticizers were employed (propylene 
glycol, dibutyl phthalate, and glycerin) to boost the film forming polymer characteristics.
Results: From this study, it is obvious that F10 which composed of HPMC as a main polymer and MD as a secondary polymer in ratio 2:1, respectively, 
provides adequate physicochemical characteristics, in vitro/in vivo DT DT (40/36 s), respectively, nevertheless a satisfactory release parameters as 
(59.9%) released at 2 min and 80% of drug released at 14.8 min.
Conclusion: The optimized formula is pretty encouraging to originate an oral strip that provides ease of administration, fast onset of action with wide 
acceptance for the pediatric population.
Keywords: Oral, Strip, Pediatric, Ease of swallowing, Hydroxypropyl methylcellulose, Maltodextrin.
INTRODUCTION
Oral route is the most preferential route of delivering the drug to the 
systemic circulation due to low cost and simplicity of administration 
that leads to enhance in patient compliance [1,2].
Many pediatric and geriatric patients are unwilling to take solid 
preparations, the problem of swallowing is a common phenomenon 
due to fear of choking, dysphasia and also in young individuals due to 
underdeveloped muscular and nervous systems as in schizophrenic 
patients which lead to poor patient compliance [3,4]. Fast dissolving 
strip as a delivery system consists of a thin, elegant films of edible 
water-soluble polymers simply placed on the patient’s tongue without 
the intake of water, instantly wet by minor amount of saliva then the 
strip rapidly disintegrates and dissolves to release the medication for 
oral mucosal absorption, to overcome the difficulties in swallowing the 
conventional oral dosage [5,6].
Due to the simplicity of administration, this technology developed over 
the past few years to become a novel and widely accepted form by 
consumers [7].
Numerous ideal characteristics of a drug to be used in preparing 
fast dissolving strip such as: The drug should have acceptable taste; 
small to moderate molecular weight is desirable, good stability and 
solubility in water because manufacturing requires solvents and heat 
for drying [8].
Chlorpheniramine maleate is a first-generation alkylamine 
antihistamine used in the prevention of the symptoms of allergic 
conditions such as rhinitis and urticaria. Antihistamines are widely 
available as both prescription and over-the-counter products for the 
treatment of allergies, runny nose, sneezing, itching, and watery eyes 
caused by allergies, the common cold, and flu [9,10].
Chlorpheniramine maleate is typically administered 2–3 times daily. 
The drug is readily and rapidly absorbed from the gastrointestinal 
tract, but the oral bioavailability is about 25–40% due to high first-
pass metabolism, as the drug is largely inactivated in the liver and 
the metabolites excreted in the urine; therefore, the onset of action is 
slow. So there is a need to formulate a dosage form which gives fast 
relief from allergic conditions and improves the bioavailability of drug, 
therefore; fast dissolving strip is the best choice [11,12].
MATERIALS AND METHODS
Materials
Chlorpheniramine Maleate and Mannitol were obtained from 
(Samara drug industry-Iraq) HPMC (15cp, 50 cp), Na CMC, PVA were 
obtained from (Provizerpharma-India), Maltodextrin was obtained 
from (Sigma-Aldrich- USA), Glycerin was obtained from (GCC-UK), 
Citric acid, Propylene glycol was purchased from (Panreac-Espana), 
Sodium saccharine was purchased from (Avonchem limit-UK), di butyl 
phthalate was purchased from (Fluka Chemika, Switzerland). All other 
reagents and chemicals used were of analytical grade.
Methods
Preparation of oral strip
Ten formulas were prepared (F1–F10), using a solvent casting method 
with different types of polymers and plasticizers, the composition is 
shown in Table 1. Drug, sodium saccharin, citric acid, mannitol, and 
plasticizers (glycerin, PG) were dissolved in a suitable volume of 
water except for the third type of plasticizer (DBT) in which 10 ml of 
3% acetic acid was used to solubilize it, with heating and continuous 
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stirring to form a clear solution. After cooling, a suitable amount of 
polymers (an aqueous preparation of film-forming polymer was 
separately arranged) was added to the previously prepared solution 
with continuous stirring for 4 h, until uniformly viscous solution 
achieved, which was kept un-disturbed for 24 h to remove the 
entrapped air. The resulting solution was poured into a 9 cm Petri dish 
and allowed to dry in hot air oven at 40°C for 24 h, the dried batch 
carefully removed and cut into 16 desired size strips, each strip has a 
surface area approximately of 4 cm2 (2 cm×2 cm) and loaded with 2 mg 
of chlorpheniramine maleate [13-15].
Evaluation of oral strips
Visual inspection
Properties such as homogeneity, color, transparency, and surface of the 
oral strips were inspected for all the prepared oral strips [16].
Thickness measurements
The thickness of the strip was measured by a micrometer screw gauge 
at different strategic points. Each strip was measured at five positions 
(center and four corners), and the mean thickness was calculated [17].
Folding endurance
The folding endurance is expressed as the number of folds (number 
of times of folding the strip at the same plain) required to break the 
specimen or developing visible cracks or folded up to 300 times 
manually, which was considered satisfactory to reveal good strip 
properties and gives an indication of brittleness of the strip [18].
Drug content uniformity
The strip was allowed to dissolve in 100 ml phosphate buffer pH 6.8 
contained in 100 ml volumetric flask, with stirrer maintained at 37°C 
for 3 h and left for 24 h at room temperature. The filtered solution 
was diluted and analyzed by UV-VIS spectrophotometer at 278 nm in 
triplicates; the average drug content was calculated [19].
Surface pH study
The surface pH of the oral dissolving strip is calculated to investigate 
the risk of any side effects in vivo, as acidic or alkaline pH may lead to 
irritation to oral mucosa and it is measured to uphold the surface pH 
close to neutral as possible. The strip was marginally hydrated with the 
help of 1 ml of distilled water and kept for 30 s. The pH was dedicated 
by bringing the electrode in contact with the surface of the strip and 
allowing it to equilibrate for 1 min. The average of three determinations 
for each film was determined [20].
Disintegration test
In vitro disintegration test
The test was performed using USP disintegration test apparatus, using 
250 ml phosphate buffer pH 6.8 at 37±0.5°C as a medium, 2 cm2×2 cm2 
strip was placed in the tube of the basket, and the disks were placed 
over it [19].
In vivo disintegration test
The time required for complete disintegration in the oral cavity was 
calculated from three healthy volunteers. The in vivo evaluations test 
was approved by the Ethics Committee of the College of Pharmacy, 
Mustansiriyah University. The mouth cavity was rinsed with a cup 
of water, the strip was placed on the tongue, and subsequently, the 
tongue was gently moved. The time required for disintegration in the 
mouth was determined. The data were represented as a mean of three 
determinations [21].
In vitro dissolution study
The dissolution study was carried out using USP dissolution apparatus 
Type II paddle apparatus in 500 ml phosphate buffer (pH 6.8) kept 
at 37±0.5°C with rotation speed of 50 rpm. A film of 4 cm2 size was 
immersed in the dissolution jar, 5 ml samples were withdrawn at the time 
interval from 2, 5, 10, 15, 20, 30, and 45 min and an equal volume of the 
fresh dissolution media at the same temperature was replenished. The 
collected samples were filtered and analyzed spectrophotometrically 
at 278 nm. The release parameters of chlorpheniramine maleate from 
strip were measured; the results were expressed as the mean of three 
determinations [17].
Statistical analysis
One-way analysis of the variance was chosen for statistical analysis 
when p<0.05 then there would be a significant statistical difference.
Variables affecting characteristics of prepared chlorpheniramine 
maleate pediatric oral strips
Effect of strip forming polymer types on in vitro/in vivo disintegration 
time (DT) and in vitro drug release profile of prepared strips
Formulas F1-F4 were prepared to study the effect of sole polymer 
types (HPMC15cp, HPMC50cp, PVA, and Na CMC), respectively, at 
concentration of 48% w/w of total dry weight on the in vivo/in vitro DT 
and in vitro drug release parameters of chlorpheniramine maleate strips.
Effect of different plasticizer types on in vitro/in vivo DT and in vitro 
drug release profile of prepared strips
Formulas F1, F5, and F6 were prepared to study the effect of changing 
the type of plasticizer (PG, DBP, and glycerin) on in vitro/in vivo DT and 
in vitro drug release profile of chlorpheniramine maleate oral strips.
Effect of different concentrations of plasticizer on in vitro/in vivo DT 
and in vitro drug release profile of prepared strips
Formulas F6 and F7 were prepared to study the effect of changing the 
concentrations of plasticizer (glycerin) from 25% to 20% w/w of total 
dry weight on the in vitro/in vivo DT and in vitro drug release profile of 
chlorpheniramine maleate oral strips.
Effect of polymeric blend and polymeric blend ratio on in vitro/in vivo 
DT and in vitro drug release profile of prepared strips
Formulas F8, F9, and F10 were prepared to study the effect of polymeric 
blend using MD as secondary polymer at different ratio of HPMC15cp: 
Table 1: Ingredients used in the preparation of chlorpheniramine maleate pediatric oral strips
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Chlorpheniramine Maleate 2 2 2 2 2 2 2 2 2 2




MD 24 32 16
DBP 25
PG 25 25 25 25
Glycerin 25 20 25 25 25
Sodium saccharin 4 4 4 4 4 4 4 4 4 4
Citric acid 2 2 2 2 2 2 2 2 2 2
Mannitol 19 19 19 19 19 19 24 19 19 19
HPMC: Hydroxypropyl methylcellulose, PVA: Polyvinyl alcohol, Na CMC: Sodium carboxymethyl cellulose, PG: Propylene glycol, DBP: Dibutyl phthalate, MD: Maltodextrin
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MD 1:1, 1:2, and 2:1, respectively, on the in vitro/in vivo DT and in vitro 
drug release profile of chlorpheniramine maleate oral films.
RESULTS AND DISCUSSION
The data of physical parameters which include: Visual inspection, 
thickness measurement, folding endurance, surface pH, and drug 
content uniformity were shown in Table 2.
Visual inspection
The appearance of all prepared chlorpheniramine maleate fast 
dissolving strips which contain different film-forming polymers 
showed homogenous, transparent, flexible, non-sticky, and smooth in 
the texture properties with elegant appearance.
Thickness measurement
The thickness of the strips is essential to be uniform as it is directly 
associated to the precision of dose. Thickness of the strips was found 
to vary between 0.04 and 0.23 mm. The low ± standard deviation (SD) 
values in the strip thickness measurements ensured uniformity of 
thickness in each formulation and the method used for the formulation 
of the strip is reproducible with dose accuracy.
Folding endurance
The folding endurance measures the ability of strip to withstand rupture 
and gives an indication of brittleness of the strip. The results showed 
that most of the formulas showed satisfactory folding endurance, while 
low folding endurance of strips below the acceptable level was found 
in the formulas that contain MD as secondary polymer (F8 [105±0.07] 
and F9 [18±0.78]) this is may be due to low viscosity of polymeric 
solution and hence the formed films were very thin. While F10 showed, 
folding endurance (>300) due to increased HPMC the main polymer 
amount [22].
Drug content uniformity
The strips prepared with various polymers were evaluated for the 
uniform dispersion of the drug throughout the strips. All the results 
indicate that the drug was uniformly dispersed throughout the films
Surface pH study
The surface pH of fast dissolving strips was determined to investigate 
the possibility of any side effects in vivo, because an acidic or alkaline 
pH may cause irritation to the oral mucosa. The surface pH of strips 
was found to be in the range of 6.21–6.9, which is within the range of 
salivary pH which indicates that there may not be any kind of irritation 
to the mucosal lining of the oral cavity. The SD values for all the strips 
were very low which indicated that the surface pH of all strips was 
uniform.
Variables affecting characteristics of the prepared 
chlorpheniramine maleate pediatric oral strip
Effect of strip forming polymer types on the in vitro/in vivo DT 
and in vitro drug release profile of prepared strips
The results of in vitro/in vivo DT of all prepared formulas were shown 
in Table 3. Typically, the in vivo DT is shorter than in vitro DT; this can 
be explained by the additional tension effect produced in the mouth 
by the tongue movement and the presence of saliva stimulating agent 
in strip composition. Four types of polymers (F1-F4) were chosen to 
study the influence of polymer type on in vitro/in vivo DT. The rank 
order of chlorpheniramine maleate oral strip in vitro/in vivo DT during 
this study is as follows: F3 (PVA) ˃F2 (HPMC 50cp) ˃F4 (Na CMC) ˃F1 
(HPMC 15cp), F3 shows increased in vitro/in vivo (DT) (90/82 s) in 
comparison with other formulas this is may be related to the increased 
thickness of PVA film in respect to other formulas which consecutively 
influenced by the viscosity of the polymer solution [23-25], while F1 
showed the shortest in vitro/in vivo DT (faster disintegration 46/40 s) 
Table 2: The physical parameters of the prepared oral strips of chlorpheniramine maleate
Formula code Appearance Film thickness mm±SD Folding endurance±SD Content uniformity Surface pH±SD
F1 Transparent 0.085±0.04 >300 98.2±0.44 6.9±0.1
F2 Transparent 0.094±0.03 >300 94.23±0.3 6.68±0.03
F3 Transparent 0.23±0.062 >300 98.5±0.11 6.8±0.08
F4 Transparent 0.129±0.05 >300 97.8±0.13 6.62±0.05
F5 Transparent 0.091±0.08 >300 95.2±0.29 6.78±0.03
F6 Transparent 0.078±0.03 >300 95.4±0.43 6.57±0.06
F7 Transparent 0.086±0.09 >300 93.7±0.21 6.83±0.42
F8 Transparent 0.061±0.07 105±0.07 98.1±0.33 6.67±0.02
F9 Semitransparent brittle in nature 0.04±0.032 18.5±0.78 91.2±0.23 6.61±0.01
F10 Transparent 0.069±0.052 >300 98.6±0.17 6.21±0.04
SD: Standard deviation
Fig. 1: The influence of sole polymer type on in vitro/in vivo disintegration time (n=3) (mean±standard deviation)
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this can be attributed to the low viscosity of HPMC15cp, in comparison 
to higher grade HPMC 50cp (83/79 s) and NA CMC (55/51 s), as 
shown in Fig. 1. A similar finding was seen in orciprenaline sulfate fast 
dissolving oral films [26].
Concerning in vitro drug release, Table 3 shows the release parameters 
for all prepared formulas. The percentage of drug being dissolved in 
2 min (D2 min) as well as the required time for releasing 80% of the 
drug (T80%) was considered for determination of in vitro drug release 
profile. The percent drug dissolved in 2 min (D2 min) was employed for 
comparison purpose due to the value of rapid drug release in case of 
fast dissolving oral strip preparations. The order of in vitro drug release 
is PVA>HPMC 15cp>Na CMC>HPMC 50cp, from Fig. 2; it is obvious that 
the F3 (PVA) showed a significant increment (p<0.05) in D2 min value 
(60.4%) and diminution in T80% (9.9 min) in comparison with other 
formulas this is may be resulted from erosion of loosely bounded PVA 
molecules on the surface due to high solubility of PVA in water [27]. 
A similar finding was reported in of levocetirizine dihydrochloride fast 
dissolving film [28]. HPMC 15cp showed the shortest DT among other 
polymer sorts, so it was selected for further study.
On the other hand, HPMC 50cp (F2) showed a significant diminution 
(p<0.05) in D2 min (40.1%) in comparison to F1 (HPMC 15cp) (55.8 %) 
and F3 (PVA) (60.4%), since HPMC 50cp produces a dense and thick 
gel formed by a fast and rapid water uptake that retards further 
hydration by dissolution media which accordingly decreases the drug 
release [29-31].
Na CMC showed a significant diminution (p<0.05) in D2 min value 
(49.6%) resulted from the fact that Na CMC is a hydrophilic polymer, 
water uptake occurs rapidly, and as consequences a stable gel layer 
will be formed that further controls the drug release [32]. HPMC 15 cp 
showed shortest disintegration time among other polymer sorts, so it 
was selected for further study
Effect of different plasticizer types on in vitro/in vivo DT and 
in vitro drug release profile of prepared strips
Dibutyl phthalate was used as plasticizer since it imparts the strength 
and flexibility to the strip that prevents the brittleness and breakage 
of the oral strip. Fig.3 showed the DT of variant types of plasticizers in 
which this study  included; F5 showed significant increment (p < 0.05) 
in in vitro/in vivo DT (88/82 seconds) among the other plasticizers, this 
is related to the increased physical strength of the polymeric structure 
caused by DBP which imparts resistance of film to break [15].
While F1 (46.2/43.8 s) and F6 (45.1/43.3 s) showed non-significant 
diminution (p>0.05) in vitro/in vivo DT this may be due to the fact 
that the two types of plasticizers enhanced the DT by facilitating the 
penetration of fluids into the strip, since plasticizer alter the densely 
packed chains of HPMC texture by forming the polymer structure 
possessing more pores and less density that breaks at lower force, 
resulting in faster disintegration of the film [33].
From in vitro release parameters in Table 3, it is obvious that the 
formula F5 that contains DBP showed a significant diminution (p<0.05) 
in D2 min (31.8%) and increment in T80% (44.9 min) in comparison to 
other sorts of plasticizers, consequently such drug release pattern may 
be accredited to the variance in water permeability and leaching ability 
from the strip structure related to nature of plasticizer types, since DBP 
is hydrophobic in nature and does not undergo leaching in contrast to 
other two hydrophilic counterparts [34].
While F1 (55.8%) and F6 (56.9%) showed, non-significant increment 
(p>0.05) in D2 min value this may be due to that both plasticizers are 
water dissolvable and they will diffuse out from the strips in watery 
media creating void spots in the strip through which distribution 
of liquid happens to enable strip breaking down leading to improve 
release profile of drug [35], as shown in Fig. 4. According to DT and 
in vitro release parameters glycerin was optimized in this study.
Fig. 3: Influence of different types of plasticizer in vitro/in vivo 
disintegration time (n=3) (mean±standard deviation)
Fig. 4: Influence of different plasticizer types on in vitro 
release profile in phosphate buffer pH 6.8 at 37±0.5°C (n=3) 
(mean±standard deviation)
Fig. 2: Influence of sole polymer type on in vitro release profile in 
phosphate buffer pH 6.8 at 37±0.5°C (n=3) (mean±standard deviation)
Table 3: The results of in vitro/in vivo DT in seconds and 




In vitro DT 
n=3(s)






F1 46.2±0.04 43.8±0.12 55.8±0.13 20.1±0.01
F2 83±0.76 79±0.31 40.1±0.03 44.8±0.13
F3 90±0.06 82±0.23 60.4±0.19 9.9±0.31
F4 55±0.13 51±0.31 49.6±0. 16 29.6±0.35
F5 88±0.76 82±0.34 31.8±0.05 44.9±0.07
F6 45.1±0.67 43.3±0.36 56.9±0.02 19.9±0.16
F7 50.3±0.87 48.5±0.76 40.1±0.32 43.47±0.03
F8 42±0.07 40±0.56 60.4±0.12 12.1±0.14
F9 38±0.56 34±0.39 62.7±0.41 9.8±0.19
F10 40±0.14 36±0.08 59.9±0.43 14.8±0.34
SD: Standard deviation, DT: Disintegration time
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Effect of different concentration of plasticizer on in vitro/in vivo 
the DT and in vitro drug release profile of prepared strips
Formula F7 was prepared to study the effect of decreasing the 
concentration of glycerin from 25% in F6 to 20% of total strip weight 
on in vitro/in vivo DT; it was noticed that when the concentration of 
plasticizer decreased to 20% there is a significant diminution (p<0.05) 
(50.3/48.5 s) in the in vitro/in vivo DT of oral films in comparison to 
F6 (45.1/43.3 s) in vitro/in vivo DT, this is maybe related to decrease 
the diffusion of fluid into the film, due to a less porous and more dense 
polymer structure which breaks at higher force, resulting in retarding 
disintegration of the film [36], as shown in Fig. 5.
Furthermore, it was notice that as the concentration of plasticizer 
decrease to 20% the release parameters D2min (40.1%) and T80% 
(43.47min) showed a significant (p < 0.05) diminution and increment in 
their values respectively , indicating that as the concentration  of water 
soluble  plasticizer (glycerin) decreased the number of void spaces 
would be decreased in the film ,through which the process of diffusion 
occurs, consequently less drug will diffuse out from the polymeric film 
[37], as shown in Fig. 6.
Effect of polymeric blend and polymeric blend ratio on in vitro/
in vivo DT and in vitro drug release profile of prepared strips
Maltodextrin is non-toxic, edible, and water-soluble film former 
polymer; it imparts good mouthfeel to the oral strip [38,39]. MD was 
incorporated in the oral strip to enhance the disintegration of strip 
and release profile of chlorpheniramine maleate. The effect of the 
incorporation of MD into the strip formulation that contains HPMC 
as main polymer was compared with F6 which contains HPMC as sole 
polymer, the effect of MD incorporated in different polymeric blend 
ratio in formulas F8 (1:1), F9 (1:2), and F10 (2:1) of (HPMC: MD) was 
shown in Fig. 7, a significant reduction (p<0.05) of in vitro/in vivo DT 
was noticed as the MD incorporated and as the ratio of maltrodextrin 
increased [F8 (42/40 seconds) and,F9 (38/34 seconds )] this may 
be related to the fact that the MD is highly water soluble which aid 
water penetration into the film structure; furthermore, the film with 
the highest amount of MD the thickness of the film would be the least; 
thus, the disintegration of the film will be enhanced [40]. While F10 the 
polymeric blend ratio of HPMC: MD is 2:1, the in vitro/in vivo DT was 
increased related to HPMC increased polymeric amount; hence, oral 
strip thickness was increased.
The in vitro release parameters revealed that the incorporation of MD 
into HPMC polymeric oral strip as in F8 (1:1) resulted in significant 
increment (p<0.05) in D2 min (60.4%) and diminution in T80% 
(12.1 min) in comparisim with F6 which contains HPMC as sole polymer 
D2 (56.9%), T80% (19.9 min), further moreincreasing the ratio of MD as 
in F9 (1:2) showed a significant increment (p<0.05) of D2 min (62.7%) 
and diminution of T80% (9.8) in comparisim with F8 as shown in Fig. 8 
this is related to the fact that incorporation of MD lead to decrease the 
viscosity of the main polymer with instant solubilization of the drug in 
water that lead to quicker drug release [22], while F10 which contained 
HPMC: MD in the ratio 2:1 resulted in significant diminution (p<0.05) 
Fig. 5: The influence of decreasing plasticizer concentration 
on in vitro/in vivo disintegration time (n=3) (mean±standard 
deviation)
Fig. 6: Influence of decreasing the concentration of plasticizer concentration on in vitro release profile in phosphate buffer pH 6.8 at 
37±0.5°C (n=3) (mean±standard deviation)
Fig. 7: Influence of polymer blend and polymeric blend ratio on in vitro/in vivo disintegration time (n=3) (mean±standard deviation)
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in D2min (59.9%) and increment in T80% (14.8 min) resulted from 
increased HPMC polymeric amount.
Although F8 and F9 showed shorter DT and improved release parameters 
in comparison to F10, their mechanical properties were not satisfactory 
(folding endurance <300) to select them as optimize formulas. Hence, 
formula F10 was selected as optimum formula among those close 
candidates of the prepared chlorpheniramine maleate oral strip.
CONCLUSION
The overall study revealed that chlorpheniramine maleate can be 
prepared successfully as pediatric oral strip using different polymers 
solely (HPMC 15cp, HPMC 50cp, PVA, and Na CMC) and in combination 
with MD as secondary polymer, F10 that contains (HPMC as a main 
polymer and MD as a secondary polymer at the ratio [2:1]) and 25% 
of glycerin as plasticizer provides satisfactory mechanical property, 
acceptable in vitro release profile and DT, which can be selected as 
optimum formula in comparison with other formulations.
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